# Hypofractionated IMRT With Temozolomide for HGG

> **NCT02082119** · NA · COMPLETED · sponsor: **Istituto Clinico Humanitas** · enrollment: 82 (actual)

## Conditions studied

- Glioma

## Interventions

- **RADIATION:** Hypofractionated IMRT

## Key facts

- **NCT ID:** NCT02082119
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02082119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02082119, "Hypofractionated IMRT With Temozolomide for HGG". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT02082119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*